Healthcare researchers and innovators are using artificial intelligence in many ways to improve patient outcomes and experience and healthcare delivery. TytoCare, Noze and Google, in partnership with the Mayo Clinic, aim to address some of the challenges of speeding up diagnosis and treatment with new AI-powered technologies.
FDA removes TytoCare AI-driven remote wheezing detection
TytoCare, a virtual care company, today announced that it has received a license from the US Food and Drug Administration for Tyto Insights for Wheeze Detection.
New Clearance adds lung acoustic analysis algorithms to TytoCare’s Smart Home Clinic.
TytoCare says the company’s lung acoustics database is the largest of its kind and could span acute care and chronic condition management, according to the announcement.
The company said: “The TytoCare Smart Home Clinic was introduced to address the home healthcare delivery gap that patients face with sound-only telehealth solutions. traditional audio/video”.
The company’s FDA-approved handheld telemedicine device and AI analyze recorded lung sounds to help clinicians remotely diagnose respiratory conditions. The company says telemedicine technology can determine if wheezing is detected in adults and children 2 years of age and older.
When telehealth is performed through telehealth, TytoCare Wheeze Detection prompts the clinician if an abnormal lung sound is suspected that suggests wheezing.
“TytoCare has found that respiratory diagnoses account for more than 40% of all diagnoses made with their virtual care solution,” the company said.
For chronic respiratory conditions, AI-powered decision-making tools can provide greater access to care, especially when healthcare resources are limited.
“Our Tyto Insight capabilities, including the Wheeze Detection algorithm, help advance our goal of enhancing the virtual care experience for all patients, clinicians, providers, and programs. health – not only by increasing the quality of care and expanding our capabilities to manage chronic care, but also by further supporting clinicians and specialists in making accurate diagnoses and fully informed remotely,” said Dedi Gilad, CEO and co-founder of TytoCare.
Scale infectious disease detection with digital odor recognition
Noze, a Canadian startup, said yesterday it has received a $1 million grant from the Bill & Melinda Gates Foundation to develop large-scale, portable disease detection.
Malaria is a leading cause of death and morbidity in many developing countries. According to the World Malaria Report 2021, almost half of the world’s population lives in areas at risk of malaria transmission, in about 87 countries and territories.
The company says an affordable and easy-to-use ventilator that can accurately detect infectious diseases could help millions of people.
According to the announcement, Noze is the world’s first breath analyzer that can detect biomarkers in breath for rapid screening and diagnosis of infectious diseases such as malaria and tuberculosis.
“The exhalation provides an amazingly revealing picture of a person’s current health due to the efficient exchange that takes place between the blood and the air in the lungs,” the company says.
By digitizing the sense of smell, the AI-powered digital odor recognition platform can detect various diseases manifesting in breath through their unique metabolic biomarkers.
“The long-term goal of this initiative is to enable global access to a reliable detection device that can help reduce the spread of disease, identifying treatment needs as early as possible,” said Noze. better and improve outcomes for patients in developing countries.”
During the COVID-19 pandemic, Noze has been monitoring airborne markers released by people infected with the Corona virus and influenza.
“Breath-based diagnostics will be a game changer for access to healthcare and the ability to launch mobile devices and make them available at scale worldwide. Ours can be a powerful new tool to combat the spread of malaria and tuberculosis, among other diseases,” Karim Aly, CEO at Noze, said in the statement.
The company says development of the diagnostic breath analyzer is targeted for completion by the end of 2023.
Google and Mayo Clinic develop AI-based radiotherapy tool
On Tuesday, Google announced that it has formalized an agreement with the Mayo Clinic to develop a radiotherapy model that helps providers automatically outline or contour around organs during CT scans.
The tech giant shared updates during The Check Up 2023, a news-focused event from Google Health. The company says it will soon publish the results of a study on a radiotherapy model developed in partnership with the Mayo Clinic.
“As of today, we are formalizing our agreement with the Mayo Clinic to further explore research, model development and commercialization,” said Dr. , in a Google blog post.
“Taking the next steps with the Mayo Clinic means we can together expand the scope of our model, with the goal of helping more patients get radiation therapy sooner,” he said.
The partnership started three years ago.
“We’ve partnered with the Mayo Clinic to begin exploring how AI can help clinicians spend less time on contouring,” Corrado said Tuesday.
The goal of cancer care is to develop an algorithm that improves the quality of radiation plans and patient outcomes, while reducing the time it takes radiation practice to develop treatment plans. targeting.
“Just as Google Maps can detect billions of buildings and roads with AI, we’ve built technology that can detect organs in CT scans and quickly outline them for experts,” Corrado said. for consideration”.
Andrea Fox is the senior editor of Healthcare IT News.
Email: [email protected]
Healthcare IT News is a publication of HIMSS Media.
